Ohtaki Yoichi, Shimizu Kimihiro, Saitoh Jun-Ichi, Kamiyoshihara Mitsuhiro, Mogi Akira, Nakazawa Seshiru, Ohno Tatsuya, Shirabe Ken
Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Department of Radiation Oncology, Faculty of Medicine, University of Toyama, Toyama, Japan.
Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):953-956. doi: 10.1093/icvts/ivy350.
Carbon ion radiotherapy (CIRT) shows higher local control rates and minimal damage to normal lung parenchyma compared with conventional radiotherapy; however, some patients experience local recurrence. The efficacy and safety of salvage surgery after CIRT for non-small-cell lung cancer are unclear. We reviewed clinical, surgical, pathological and prognostic data of 6 patients who underwent salvage surgery after CIRT between 2010 and 2015. All patients were men with a smoking history, and their median age was 67 years. The time from CIRT to surgery was 18 (range 12-24) months. All patients underwent at least lobectomy with mediastinal node dissection. Viable tumour cells were confirmed pathologically in all cases. Five patients required combined resection or extra procedure because of strong adhesions and the possibility of tumour extension; however, none of the patients had a tumour invasion to the adjacent organ. None of the patients had severe complications, perioperative death and local recurrence, and 3 patients are alive without recurrence (range 28-84 months). Salvage surgery appears to be safe and effective. Even though the tumours did not invade the adjacent organs, combined resection was required because of severe adhesion.
与传统放疗相比,碳离子放疗(CIRT)显示出更高的局部控制率,且对正常肺实质的损伤最小;然而,一些患者会出现局部复发。CIRT后挽救性手术治疗非小细胞肺癌的疗效和安全性尚不清楚。我们回顾了2010年至2015年间6例接受CIRT后挽救性手术患者的临床、手术、病理和预后数据。所有患者均为有吸烟史的男性,中位年龄为67岁。从CIRT到手术的时间为18个月(范围12 - 24个月)。所有患者均至少接受了肺叶切除术及纵隔淋巴结清扫术。所有病例经病理证实均有存活肿瘤细胞。5例患者因粘连严重及可能存在肿瘤侵犯而需要联合切除或额外手术;然而,所有患者均未发生肿瘤侵犯邻近器官。所有患者均未出现严重并发症、围手术期死亡及局部复发,3例患者存活且无复发(范围28 - 84个月)。挽救性手术似乎是安全有效的。尽管肿瘤未侵犯邻近器官,但由于粘连严重仍需要联合切除。